Compare Carparts.Com Inc (PRTS) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carparts.Com Inc vs GeneDx Holdings Corp — how do they compare? Carparts.Com Inc trades at $4.43 (market cap $39.44M), while GeneDx Holdings Corp trades at $62.68 (market cap $1.83B). The key difference: GeneDx Holdings Corp is far larger — about 46.4× Carparts.Com Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Carparts.Com Inc nearer its low. Which is the better fit depends on your goals.
| PRTS | WGS | |
|---|---|---|
Market Cap | $39.44M | $1.83B |
Sector | Consumer Cyclical | Technology |
52-Week High | $11.40 | $167.51 |
52-Week Low | $3.88 | $34.51 |
Enterprise Value | $54.41M | $1.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PRTS trades at $4.85, down 8.49% today, reflecting a bearish technical trend. The company reported a net loss of $50.44M in 2025 despite revenue of $547.53M, with negative cash flow from operations. Recent developments include a reverse stock split and a new $25M credit facility, while analysts maintain a 60% buy rating. The stock shows oversold conditions with RSI levels below 30, indicating potential for a near-term bounce.
The outlook remains challenging due to persistent losses and negative cash flow, though cost-cutting measures and recent earnings beats offer some optimism. Key risks include execution on profitability and competitive pressures. The stock presents a high-risk opportunity for investors betting on a turnaround, supported by analyst bullishness but tempered by fundamental weaknesses.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
